TRS
Back to Database

CJC-1295

Experimental

Also known as: Modified GRF 1-29, Mod-GRF

Growth Hormone PeptidesSubcutaneous

A synthetic analog of growth hormone-releasing hormone (GHRH). Available with or without Drug Affinity Complex (DAC) which extends half-life.

Molecular Weight3367.9 Da (no DAC) / 3647.3 Da (with DAC)
Half-Life (t½)30 min (no DAC) / 6-8 days (with DAC)
SequenceYADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL

Mechanism of Action

Stimulates pituitary gland to release growth hormone in a pulsatile, physiological manner. Preserves natural GH feedback loops.

Dosing Protocol

No DAC: 100 mcg 2-3x daily (before bed, AM, post-workout). With DAC: 2mg once weekly.

Open peptide calculator

Reconstitution

2mg vial + 2mL BAC water = 1000 mcg/mL.

Storage

Lyophilized: -20°C. Reconstituted: 2-8°C.

Side Effects

  • ●Flushing
  • ●Headache
  • ●Water retention
  • ●Tingling/numbness

Key Research Findings

  • ●Sustained GH elevation for 6+ days (with DAC)
  • ●Increased IGF-1 levels by 50-70%
  • ●Improved body composition in clinical studies

Latest Verified Lab Report

No lab reports available for CJC-1295 yet.

Community-funded testing results will appear here.

Vendor Trust Leaderboard

For CJC-1295

Trust leaderboard coming soon.

Vendor rankings based on verified lab test results.

Active Deals

Gen Peptide
10% OFF
G
Shop Vendor
Advertisement

Sponsored Ad Space

Advertise with us

Research Use Only

This information is provided for educational and research purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before using any research compounds.